Fingerprint
Dive into the research topics of 'The addition of the farnesyl transferase inhibitor, tipifarnib, to low dose cytarabine does not improve outcome for older patients with AML'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically